Cited by 4,649Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, Lawrence A., Harvey, Michele, Slagle, Betty L., McArthur, Mark J., Montgomery, Charles A., Butel, Janet S., Bradley, Allan·1992·Nature

DOI 10.1038/356215a0

Open this paper in CoChat — free account

Abstract

Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.

Integrity signals

Registry

Crossref · 10.1038/356215a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997
Self-citation
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683

Show all 48 references

Research works printed but not linked: 10

Mowat, M., Cheng, A., Kicumca, N., Bernstein, A. & Benchimol, S. Nature 61, 2777–2781 (1985).
Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S. & Bernstein, A. Oncogene 3, 179–185 (1988).
Stürzbecher, H.-W. et al. Oncogene 5, 795–801 (1990).
Shaulsky, G., Ben-Ze'ev, A. & Rotter, V. Oncogene 5, 1707–1711 (1990).
Soussi, T., de Fromentel, C. C. & May, P. Oncogene 5, 945–952 (1990).
Bradley, A. in Tetratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. J.) 113–151 (IRL, Oxford, 1987).
Stutman, O. Fed. Proc. Fed. Am. Soc. exp. Biol. 33, 2028–2032 (1974).
Yandell, D. W. Proc. Am. Assoc. Cancer Res. 32, 459–460 (1991).
Sepulveda, A. R. et al. Cancer Res. 49, 6108–6117 (1989).
Slagle, B. L., Lanford, R. E., Medina, D. & Butel, J. S. Cancer Res. 42, 2155–2162 (1984).

Sorted by citations

Items 701–800 of 1,032

Deletion of Ku70, Ku80, or Both Causes Early Aging without Substantially Increased Cancer
Li, H., Vogel, H. S., Holcomb, V. B., Gu, Y., & Hasty, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00785-07 · Cited by 158
The role of tumor suppressor p53 in the antioxidant defense and metabolism
Budanov, A. V. (2014) · Subcellular Biochemistry · doi:10.1007/978-94-017-9211-0_18 · Cited by 157
Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression
Beverly, L. J., Felsher, D. W., & Capobianco, A. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1664 · Cited by 157
Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice.
Edelmann, W., Yang, K., Kuraguchi, M., Heyer, J., Lia, M., Kneitz, B., Fan, K., Brown, A. M. C., Lipkin, M., & Kucherlapati, R. (1999) · PubMed · Cited by 157
α-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis
Hayakawa, Y., Rovero, S., Forni, G., & Smyth, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630663100 · Cited by 157
Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase
Yao, S.-L., Akhtar, A. J., Mckenna, K. A., Bedi, G. C., Sidransky, D., Mabry, M. H., Ravi, R. K., Collector, M. I., Jones, R. J., Sharkis, S. J., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1140 · Cited by 157
Genetic polymorphisms in cell cycle regulatory genesMDM2 andTP53 are associated with susceptibility to lung cancer
Zhang, X., Miao, X., Guo, Y., Tan, W., Zhou, Y., Sun, T., Wang, Y., & Lin, D. (2005) · Human Mutation · doi:10.1002/humu.20277 · Cited by 156
USP4 inhibits p53 through deubiquitinating and stabilizing ARF‐BP1
Zhang, X., Berger, F. G., Yang, J., & Lu, X. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.125 · Cited by 156
Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin
Martini, R., Mohajeri, M. H., Kasper, S. F., Giese, K.-P., & Schachner, M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04488.1995 · Cited by 156
The p53-Binding Protein 53BP2 Also Interacts with Bcl2 and Impedes Cell Cycle Progression at G 2 /M
Naumovski, L., & Cleary, M. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3884 · Cited by 156
Tumor suppressor p53: regulation and function
Somasundaram, K. (2000) · Frontiers in bioscience · doi:10.2741/somasund · Cited by 155
BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks
Zhong, Q., Chen, C., Chen, P., & Lee, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200748200 · Cited by 155
Interaction of p53 with Its Consensus DNA-Binding Site
Wang, Y., Schwedes, J. F., Parks, D., Mann, K., & Tegtmeyer, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2157 · Cited by 155
Involvement of p85 in p53-dependent apoptotic response to oxidative stress
Yin, Y., Terauchi, Y., Solomon, G. G., Aizawa, S., Rangarajan, P. N., Yazaki, Y., Kadowaki, T., & Barrett, J. C. (1998) · Nature · doi:10.1038/35648 · Cited by 155
Does p53 affect organismal aging?
Donehower, L. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10104 · Cited by 155
Self-citation
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
Jiang, M., & Dong, Z. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139162 · Cited by 155
Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases.
Milne, D., Campbell, D. G., Caudwell, F. B., & Meek, D. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37101-6 · Cited by 154
The tumor suppressorsInk4candp53collaborate independently withPatchedto suppress medulloblastoma formationPreprint
Uziel, T., Zindy, F., Xie, S., Lee, Y., Forget, A., Magdaleno, S. M., Rehg, J. E., Calabrese, C. R., Solecki, D. J., Eberhart, C. G., et al. (2005) · Genes & Development · doi:10.1101/gad.1368605 · Cited by 154
The regulation of cellular metabolism by tumor suppressor p53
Liang, Y., Liu, J., & Feng, Z. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-9 · Cited by 154
Inhibition of the p53-MDM2 Interaction: Targeting a Protein-Protein Interface
Chêne, P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.20.2.1 · Cited by 153
Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons
Vogel, K. S., Brannan, C. I., Jenkins, N. A., Copeland, N. G., & Parada, L. F. (1995) · Cell · doi:10.1016/0092-8674(95)90470-0 · Cited by 153
p53 and the Li-Fraumeni syndrome
Malkin, D. M. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90233-c · Cited by 153
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2Preprint
Zhang, Y., Qian, Y., Zhang, J., Yan, W., Jung, Y.-S., Chen, M., Huang, E. C., Lloyd, K. C. K., Duan, Y., Wang, J., et al. (2017) · Genes & Development · doi:10.1101/gad.299388.117 · Cited by 153
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Giuriato, S., Ryeom, S. W., Fan, A. C., Bachireddy, P., Lynch, R. C., Rioth, M. J., van Riggelen, J., Kopelman, A. M., Passegue, E. A., Tang, F. L. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608017103 · Cited by 152
Melanoma: From Melanocyte to Genetic Alterations and Clinical Options
Bertolotto, C. (2013) · Scientifica · doi:10.1155/2013/635203 · Cited by 152
Molecular Comparison of Human and Mouse Pulmonary Adenocarcinomas
Malkinson, A. M. (1998) · Experimental Lung Research · doi:10.3109/01902149809087385 · Cited by 152
Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected
Brinkley, B. R., & Goepfert, T. M. (1998) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1998)41:4 · Cited by 152
Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors
Maronpot, R. R., Fox, T., Malarkey, D. E., & Goldsworthy, T. L. (1995) · Toxicology · doi:10.1016/0300-483x(95)03112-s · Cited by 152
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151
Irradiation selects for p53-deficient hematopoietic progenitors.
Marusyk, A., Porter, C. C., Zaberezhnyy, V., & DeGregori, J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000324 · Cited by 151
p53-Mediated Germ Cell Quality Control in Spermatogenesis
Yin, Y., Stahl, B. C., DeWolf, W. C., & Morgentaler, A. (1998) · Developmental Biology · doi:10.1006/dbio.1998.9074 · Cited by 151
The cell death machinery governed by the p53 tumor suppressor in response to DNA damage
Yoshida, K., & Miki, Y. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01488.x · Cited by 151
Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies
Wickremasinghe, R. G., & Hoffbrand, A. V. (1999) · Blood · doi:10.1182/blood.v93.11.3587 · Cited by 151
Sequence‐specific DNA binding by p53: identification of target sites and lack of binding to p53 ‐ MDM2 complexes.
Zauberman, A., Barak, Y., Ragimov, N., Levy, N., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05941.x · Cited by 151
Studies of neoplasia in the Min mouse1C57BL/6J Min/+ mice are available worldwide from The Jackson Laboratory, Bar Harbor, ME 04609, USA.1
Shoemaker, A. R., Gould, K. A., Luongo, C., Moser, A. R., & Dove, W. F. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00041-8 · Cited by 151
Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice.
KADO, S., Uchida, K., Funabashi, H., Iwata, S., Nagata, Y., Ando, M., Onoue, M., Matsuoka, Y., Ohwaki, M., & Morotomi, M. (2001) · PubMed · Cited by 150
p53 downregulates Down syndrome‐associated DYRK1A through miR‐1246
Zhang, Y., Liao, J., Zeng, S. X., & Lu, H. (2011) · EMBO Reports · doi:10.1038/embor.2011.98 · Cited by 150
The Role of p53 in Cell Cycle Regulation
Shaw, P. H. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80088-4 · Cited by 150
p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein
Poller, D. N., Roberts, E., Bell, J. A., Elston, C. W., Blamey, R. W., & Ellis, I. O. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90157-c · Cited by 150
p53, guardian of Rb
White, E. (1994) · Nature · doi:10.1038/371021a0 · Cited by 150
ATM–Chk2–p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency
Cao, L., Kim, S., Xiao, C., Wang, R., Coumoul, X., Wang, X., Li, W. M., Xu, X. L., Soto, J. A. D., Takai, H., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601115 · Cited by 150
Phosphorylation of Human p53 at Serine 46 Determines Promoter Selection and whether Apoptosis Is Attenuated or Amplified
Mayo, L. D., Seo, Y. R., Jackson, M. W., Smith, M. L., Guzman, J. R., Korgaonkar, C. K., & Donner, D. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503026200 · Cited by 149
Generation of medaka gene knockout models by target-selected mutagenesis
Taniguchi, Y., Takeda, S., Furutani‐Seiki, M., Kamei, Y., Todo, T., Sasado, T., Deguchi, T., Kondoh, H., Mudde, J., Yamazoe, M., et al. (2006) · Genome biology · doi:10.1186/gb-2006-7-12-r116 · Cited by 149
Apoptosis, cancer and the p53 tumour suppressor gene
Lee, J. M., & Bernstein, A. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00665797 · Cited by 149
p53 cooperates berberine‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo
Katiyar, S. K., Meeran, S. M., Katiyar, N., & Akhtar, S. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20453 · Cited by 148
Apoptosis and Programmed Cell Death in Health and Disease
Vermes, I., & Haanen, C. (1994) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60336-4 · Cited by 148
Prognostic significance of p53 immunostaining in epithelial ovarian cancer.
Hartmann, L. C., Podratz, K. C., Keeney, G. L., Kamel, N. A. M. H., Edmonson, J. H., Grill, J., su, J., Katzmann, J. A., & Roche, P. C. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.64 · Cited by 148
Cell competition: the winners and losers of fitness selection
Bowling, S., Lawlor, K., & Rodríguez, T. A. (2019) · Development · doi:10.1242/dev.167486 · Cited by 147
p53 and MDM2 alterations in osteosarcomas
Lonardo, F., Ueda, T., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8 · Cited by 147
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
Ha, L., Ichikawa, T., Anver, M. R., Dickins, R. A., Lowe, S. W., Sharpless, N. E., Krimpenfort, P., DePinho, R. A., Bennett, D. C., Sviderskaya, E. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611638104 · Cited by 147
Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor
Hettmann, T., Barton, K., & Leiden, J. M. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9699 · Cited by 147
Transgenic mouse models of human breast cancer
Hutchinson, J. N., & Muller, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203970 · Cited by 147
The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatin
Zhang, H.-Y., Han, Q.-W., Xu, Y.-F., Fan, Y.-R., Dai, Q.-M., Zhu, H.-W., Rong, Z.-G., Wang, J.-J., & Xu, G.-X. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1442 · Cited by 147
Tumor suppressor genes
Weinberg, R. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90177-s · Cited by 147
p53 GENE MUTATIONS AND PHOTOCARCINOGENESIS
Nataraj, A. J., Trent, J. C., & Ananthaswamy, H. N. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb05262.x · Cited by 147
p63 and epithelial biology
Barbieri, C. E., & Pietenpol, J. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.028 · Cited by 146
The loss of mdm2 induces p53 mediated apoptosis
de Rozìeres, S., Maya, R. B.-Y., Oren, M., & Lozano, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203468 · Cited by 146
Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo
Castedo, M., Macho, A., Zamzami, N., Hirsch, T., Marchetti, P., Uriel, J., & Kroemer, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251212 · Cited by 146
Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53Preprint
Pfister, N. T., & Prives, C. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026054 · Cited by 146
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
Komarova, E. A., Antoch, M. P., Novototskaya, L. R., Chernova, O. B., Paszkiewicz, G., Leontieva, O. V., Blagosklonny, M. V., & Gudkov, A. V. (2012) · Aging · doi:10.18632/aging.100498 · Cited by 145
p53 in embryonic development: maintaining a fine balance
Choi, J. M., & Donehower, L. A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050268 · Cited by 145
Self-citation
Green Tea Constituent (–)-Epigallocatechin-3-Gallate Inhibits Hep G2 Cell Proliferation and Induces Apoptosis through p53-Dependent and Fas-Mediated Pathways
Kuo, P., & Lin, C. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256057 · Cited by 145
DNA Double-Strand Breaks
Bross, L., Muramatsu, M., Kinoshita, K., Honjo, T., & Jacobs, H. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011749 · Cited by 145
A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19 ARF –p53 signalingPreprint
Shvarts, A., Brummelkamp, T. R., Scheeren, F., Koh, E., Daley, G. Q., Spits, H., & Bernards, R. (2002) · Genes & Development · doi:10.1101/gad.929302 · Cited by 145
Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose γ-irradiation
Yu, H. M., Shen, H., Yuan, Y., XuFeng, R., Hu, X., Garrison, S. P., Zhang, L., Yu, J., Zambetti, G. P., & Cheng, T. (2010) · Blood · doi:10.1182/blood-2009-10-248278 · Cited by 144
The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure
Toufektchan, E., & Toledo, F. (2018) · Cancers · doi:10.3390/cancers10050135 · Cited by 144
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome
Labuhn, M., Perkins, K., Matzk, S., Varghese, L. N., Garnett, C., Papaemmanuil, E., Metzner, M., Kennedy, A., Amstislavskiy, V. S., Risch, T., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.06.007 · Cited by 145
Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a
Hollander, M. C., & Fornace, A. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205774 · Cited by 144
The regulation of p53 function: Steiner award lecture
Lane, D. P. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570502 · Cited by 144
Targeting Frequency for Deletion Vectors in Embryonic Stem Cells
Zhang, H., Hasty, P., & Bradley, A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2404 · Cited by 144
Self-citation
p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis
Su, X., Chakravarti, D., & Flores, E. R. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3446 · Cited by 143
Tumor suppressive role for kinases phosphorylating p53 in DNA damage‐induced apoptosis
Yogosawa, S., & Yoshida, K. (2018) · Cancer Science · doi:10.1111/cas.13792 · Cited by 143
Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses
Fontemaggi, G., Kela, I., Amariglio, N., Rechavi, G., Krishnamurthy, J., Strano, S., Sacchi, A., Givol, D., & Blandino, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205573200 · Cited by 143
Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
Alarcon, R. M., Koumenis, C., Geyer, R. K., Maki, C. G., & Giaccia, A. J. (1999) · PubMed · Cited by 143
The Emerging p53 Gene Family
Kaelin, W. G. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.594 · Cited by 143
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., & Kaufmann, W. K. (1995) · PubMed · Cited by 143
Self-citation
Update on Human Polyomaviruses and Cancer
Gjoerup, O. V., & Chang, Y. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06001-x · Cited by 142
Structure of Free MDM2 N-terminal Domain Reveals Conformational Adjustments that Accompany p53-binding
Uhrı́nová, S., Uhrı́n, D., Powers, H., Watt, K., Zheleva, D. I., Fischer, P. M., McInnes, C., & Barlow, P. N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.05.010 · Cited by 142
BAX and BAK mediate p53-independent suppression of tumorigenesis
Degenhardt, K., Chen, G., Lindsten, T., & White, E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00126-5 · Cited by 142
Prospective therapeutic applications of p53 inhibitors
Gudkov, A. V., & Komarova, E. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.153 · Cited by 142
ΔNp63α functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes
King, K. E., Ponnamperuma, R. M., Yamashita, T., Tokino, T., Lee, L. A., Young, M. F., & Weinberg, W. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206536 · Cited by 142
Tumor Suppressor p53 Inhibits Autoimmune Inflammation and Macrophage Function
Zheng, S. J., Lamhamedi-Cherradi, S.-E., Wang, P., Xu, L., & Chen, Y. H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1423 · Cited by 142
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock
Munro, J., Barr, N. I., Ireland, H., Morrison, V., & Parkinson, E. K. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.017 · Cited by 141
Wip1-Dependent Regulation of Autophagy, Obesity, and Atherosclerosis
Guezennec, X. L., Brichkina, A. I., Huang, Y.-F., Kostromina, E. Y., Han, W., & Bulavin, D. V. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.003 · Cited by 141
p73, a sophisticated p53 family member in the cancer world
Ozaki, T., & Nakagawara, A. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00116.x · Cited by 141
Introduction: p53 – the first twenty years
Oren, M., & Rotter, V. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050265 · Cited by 141
TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study
Wunder, J. S., Gökgöz, N., Parkes, R. K., Bull, S. B., Eskandarian, S., Davis, A. M., Beauchamp, C. P., Conrad, E. U., Grimer, R. J., Healey, J. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.074 · Cited by 141
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma
Shi, D. D., Savani, M. R., Levitt, M. M., Wang, A. C., Endress, J. E., Bird, C. E., Buehler, J., Stopka, S. A., Regan, M. S., Lin, Y., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.07.011 · Cited by 140
Chk2 is dispensable for p53-mediated G 1 arrest but is required for a latent p53-mediated apoptotic response
Jack, M. T., Woo, R. A., Hirao, A., Cheung, A., Mak, T. W., & Lee, P. W. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152053599 · Cited by 140
The role of transgenic mouse models in carcinogen identification.
Pritchard, J. B., French, J. E., Davis, B. J., & Haseman, J. K. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.5778 · Cited by 140
Null Mutation of DNA Strand Break-Binding Molecule Poly(ADP-ribose) Polymerase Causes Medulloblastomas in p53−/− Mice
Tong, W., Ohgaki, H., Huang, H., Granier, C., Kleihues, P., & Wang, Z. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63825-4 · Cited by 140
Differential Recognition of Response Elements Determines Target Gene Specificity forp53 and p63
Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A. I., Kim, M. S., Wu, G., Nomoto, S., Trink, B., & Sidransky, D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6077-6089.2005 · Cited by 140
Growth Suppression of Friend Virus-Transformed Erythroleukemia Cells by p53 Protein Is Accompanied by Hemoglobin Production and Is Sensitive to Erythropoietin
Johnson, P., Chung, S. W., & Benchimol, S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1456-1463.1993 · Cited by 140
NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma
Zhao, S., Kurenbekova, L., Gao, Y., Roos, A., Creighton, C. J., Rao, P., Hicks, J., Man, T.-K., Lau, C., Brown, A. M. C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.429 · Cited by 139
Self-citation
Rebuilding cancer metastasis in the mouse
Saxena, M. T., & Christofori, G. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.009 · Cited by 139
Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response
Mulderrig, L., Garaycoechea, J. I., Tuong, Z. K., Millington, C. L., Dingler, F. A., Ferdinand, J. R., Gaul, L., Tadross, J. A., Arends, M. J., O’Rahilly, S., et al. (2021) · Nature · doi:10.1038/s41586-021-04133-7 · Cited by 139
Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiers
Halberg, R. B., Katzung, D. S., Hoff, P. D., Moser, A. R., Cole, C. E., Lubet, R. A., Donehower, L. A., Jacoby, R. F., & Dove, W. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3461 · Cited by 139
Self-citation
Chromatin remodeling in Cancer: A Gateway to regulate gene Transcription
Nair, S. S., & Kumar, R. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.005 · Cited by 139
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
Renault, V. M., Thekkat, P. U., Hoang, K., White, J. L., Brady, C. A., Brož, D. K., Venturelli, O. S., Johnson, T. M., Oskoui, P. R., Xuan, Z., et al. (2011) · Oncogene · doi:10.1038/onc.2011.35 · Cited by 139

Authors: Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A.
Affiliations: Baylor College of Medicine (US)
ORCID: Slagle, Betty L.
Butel, Janet S.
Bradley, Allan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1992-03
Volume: 356
Issue: 6366
Pages: 215-221
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/356215a0
OpenAlex: W2126679757
Cited by: 4,649
References: 48
Citations by year: 2026: 16 · 2025: 48 · 2024: 51 · 2023: 74 · 2022: 76 · 2021: 80 · 2020: 86 · 2019: 92 · 2018: 84 · 2017: 96 · 2016: 119 · 2015: 89 · 2014: 121 · 2013: 146 · 2012: 157
FWCI: 82.13
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, spontaneous tumors, carcinogenesis, embryonic development, mouse model, neoplasms
MeSH terms: Alleles, Animals, Base Sequence, Blastocyst, DNA, Exons, Female, Genetic Vectors, Heterozygote, Homozygote, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Mutation, Neoplasms, Experimental, RNA, Messenger, Stem Cells, Blotting, Southern, Polymerase Chain Reaction, Genes, p53, Tumor Suppressor Protein p53, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks